Paclitaxel in antiangiogenic chemotherapy
10.3760/cma.j.issn.1673-422X.2011.09.007
- VernacularTitle:紫杉醇抗血管生成化疗的研究进展
- Author:
Mingyue RAO
;
Xingping ZHANG
- Publication Type:Journal Article
- Keywords:
Paclitaxel;
Angiogenesis inhibitors;
Vascular endothelial growth factors
- From:
Journal of International Oncology
2011;38(9):664-667
- CountryChina
- Language:Chinese
-
Abstract:
Traditional chemotherapy mostly caused the proliferative cancer cells'deoxyribonucleic acid damaged and suspended copy.It is purposed to kill cancer cells as far as possible.So we adopted chemotherapeutics' human maximum tolerated dose clinically.Recent findings indicate that some chemotherapy drugs such as paclitaxel are applied under way in the low dose and high frequency could inhibit tumor angiogenesis.
